Cargando…

MRI and Active Surveillance for Prostate Cancer

Detalles Bibliográficos
Autores principales:	Porreca, Angelo, Colicchia, Michele, Busetto, Gian Maria, Ferro, Matteo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459964/ https://www.ncbi.nlm.nih.gov/pubmed/32823810 http://dx.doi.org/10.3390/diagnostics10080590

Ejemplares similares

The combination of waterjet ablation (Aquabeam(®)) and holmium laser power for treatment of symptomatic benign prostatic hyperplasia: early functional results
por: D’Agostino, Daniele, et al.
Publicado: (2021)

Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)
por: Ferro, Matteo, et al.
Publicado: (2017)

Beyond PSA: The Role of Prostate Health Index (phi)
por: Ferro, Matteo, et al.
Publicado: (2020)

Assessment of PSIM (Prostatic Systemic Inflammatory Markers) Score in Predicting Pathologic Features at Robotic Radical Prostatectomy in Patients with Low-Risk Prostate Cancer Who Met the Inclusion Criteria for Active Surveillance
por: Ferro, Matteo, et al.
Publicado: (2021)

Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study
por: Porreca, Angelo, et al.
Publicado: (2020)

Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center
por: Annese, Pasquale, et al.
Publicado: (2021)

Does obesity impact bladder cancer prognosis?—a long-lasting debate
por: Dal Moro, Fabrizio, et al.
Publicado: (2018)

The Role of MRI in Prostate Cancer Active Surveillance
por: Johnson, Linda M., et al.
Publicado: (2014)

Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance
por: Ferro, Matteo, et al.
Publicado: (2016)

T-L technique for HoLEP: perioperative outcomes of a large single-centre series
por: Porreca, Angelo, et al.
Publicado: (2021)

Multiparametric MRI in Prostate Cancer
por: Esen, Tarık, et al.
Publicado: (2014)

Eye of the beholder—Tales from Prostate Cancer Active Surveillance Development
por: Davis, John W.
Publicado: (2021)

A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data
por: Maggi, Martina, et al.
Publicado: (2021)

Repeat multiparametric MRI in prostate cancer patients on active surveillance
por: Eineluoto, Juho T., et al.
Publicado: (2017)

Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies
por: Ferro, Matteo, et al.
Publicado: (2020)

Body mass index and age correlate with antioxidant supplementation effects on sperm quality: Post hoc analyses from a double‐blind placebo‐controlled trial
por: Busetto, Gian Maria, et al.
Publicado: (2020)

Current concepts in multiparametric magnetic resonance imaging for active surveillance of prostate cancer
por: Cavalcante, Alexandre, et al.
Publicado: (2018)

Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity
por: Busetto, Gian Maria, et al.
Publicado: (2020)

PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study
por: Bruno, Salvatore M., et al.
Publicado: (2021)

BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored
por: Crocetto, Felice, et al.
Publicado: (2021)

Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy
por: Busetto, Gian Maria, et al.
Publicado: (2020)

Surveillance Value of Apparent Diffusion Coefficient Maps: Multiparametric MRI in Active Surveillance of Prostate Cancer
por: Georgiev, Aleksandar, et al.
Publicado: (2023)

Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

High-Risk Prostate Cancer: A Very Challenging Disease in the Field of Uro-Oncology
por: Napodano, Giorgio, et al.
Publicado: (2021)

Multiparametric-MRI and Targeted Biopsies in the Management of Prostate Cancer Patients on Active Surveillance
por: Sandler, Kiri, et al.
Publicado: (2015)

Multiparametric MRI in Active Surveillance of Prostate Cancer: An Overview and a Practical Approach
por: Lee, Chau Hung, et al.
Publicado: (2021)

The utility of prostate MRI within active surveillance: description of the evidence
por: Dominique, Georgina, et al.
Publicado: (2021)

Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer
por: Ferro, Matteo, et al.
Publicado: (2022)

False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillance
por: Quon, Jeffrey S., et al.
Publicado: (2015)

From PROMIS to PRO-MRI in primary prostate cancer diagnosis
por: Schoots, Ivo G., et al.
Publicado: (2017)

The role of PSA density in the MRI pathway for prostate cancer diagnostics
por: Cash, Hannes, et al.
Publicado: (2022)

SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study
por: Maggi, Martina, et al.
Publicado: (2021)

Narrative review of Mediterranean diet in Cilento: longevity and potential prevention for prostate cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

MRI-derived radiomics model for baseline prediction of prostate cancer progression on active surveillance
por: Sushentsev, Nikita, et al.
Publicado: (2021)

Active surveillance for prostate cancer
por: Dall’Era, Marc A., et al.
Publicado: (2018)

Active surveillance for prostate cancer
por: Shill, Daniela K., et al.
Publicado: (2021)

Multiparametric MRI of the prostate: the hope for the urology community
por: Kozikowski, Mieszko, et al.
Publicado: (2016)

Prostate Health Index and Multiparametric MRI: Partners in Crime Fighting Overdiagnosis and Overtreatment in Prostate Cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence
por: Glaser, Zachary A., et al.
Publicado: (2018)

AI-assisted biparametric MRI surveillance of prostate cancer: feasibility study
por: Roest, C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qsia9ehocboc7u68adupkq61sp